After the multiple myeloma CAR-T therapy approval, eyes will now be on the FDAs decision regarding Opdivos use for additional indications, as well as Zeposia in ulcerative colitis. Abecma was being developed by Bristol Myers Squibb and bluebird bio Inc. CAR-T therapy refers to extraction of a patients own T cells, which are then genetically modified and infused back into the patients body. Crown Crafts Inc designs, markets and distributes infant, toddler and juvenile consumer products. That said, the recent approval marks the only approved CAR-T therapy for the treatment of multiple myeloma. These T-Cells target and destroy any abnormal cells, including cancer cells.
Crown Crafts and Abedges cost 19.49 million whose own T-Cells destroyed abnormal cells.
( z0 cost :ARG1 ( z1 and :mod ( z2 exact ) :op ( z3 craft ) :part ( z4 cell :name ( z5 name :op "Crown" ) :ARG0-of ( z6 destroy :ARG1 ( z7 cell :ARG1-of ( z8 normal ) ) ) ) ) :ARG2 ( z9 monetary-quantity :quant 19 :unit ( z10 dollar ) ) )
(z0 / cost-01
    :ARG1 (z1 / and
              :mod (z2 / exact)
              :op1 (z3 / craft-01)
              :part (z4 / cell
                        :name (z5 / name
                                  :op1 "Crown")
                        :ARG0-of (z6 / destroy-01
                                     :ARG1 (z7 / cell
                                               :ARG1-of (z8 / normal-02)))))
    :ARG2 (z9 / monetary-quantity
              :quant 19
              :unit (z10 / dollar)))
Crown Crafts and Abedges cost 19.49 million whose own T - Cells destroyed abnormal cells .
z1 :op1 z3
z1 :mod z2
z0 :ARG1 z1
z0 :ARG2 z9
z9 :unit z10
z9 :quant 0
z1 :part z4
z4 :name z5
z5 :op1 1
z4 :ARG0-of z6
z7 :ARG1-of z8
z6 :ARG1 z7